Digital Pathology and the Future Structure of the Pathology Industry
Overview
Digital pathology is often discussed as a technical upgrade: glass slides are scanned, images are viewed on monitors, and pathologists gain tools for remote review, collaboration, and artificial intelligence.
But the larger question is industrial. Once anatomic pathology becomes digital-first, who reads the cases, where are they read, and how does the profession reorganize itself? Radiology offers a useful comparison, but not a perfect one. Digital radiology enabled teleradiology, subspecialty networks, and some large-scale consolidation of radiologists - yet it did not eliminate local radiology. Pathology is likely to follow a similar but distinct path: more networked, more subspecialized, and more consolidated, but still anchored in local specimen workflows.
The Glass-Slide Cliff
Among the major diagnostic fields, radiology and clinical laboratory medicine crossed the digital bridge earlier. Advanced imaging converts the physical patient into pixels through CT, MRI, PET, ultrasound, and related modalities. Clinical laboratory medicine converts blood, tissue, and other specimens into structured digital results: sodium 140, hemoglobin 13.5, EGFR positive, tumor mutational burden 12.
Anatomic pathology has remained different. Its central diagnostic object is still the physical glass slide. In many institutions, the pathology workflow effectively stops at that slide as if at a cliff. The case can be reviewed locally, mailed for consultation, or carried to a tumor board, but the diagnostic object itself remains physical and location-bound.
Whole-slide imaging changes that. Once slides are digitized, anatomic pathology can enter the same networked diagnostic environment that radiology and laboratory medicine already occupy. Slides can be routed, shared, archived, compared, reviewed at tumor boards, paired with radiology and molecular data, and analyzed by AI-enabled tools. The practical effect is not just modernization. It changes the geography and economics of pathology.
The Consolidation Question
The most obvious forecast is consolidation. If a slide can be scanned in one hospital and read anywhere, why must interpretation remain local? Routine cases could be routed to regional hubs. Complex cases could go to subspecialty experts. Overflow work could be assigned to national reading networks. In principle, large pathology groups could employ hundreds or thousands of pathologists, many working remotely from home workstations.
The analogy to radiology is unavoidable. Digital radiology enabled teleradiology, after-hours coverage, subspecialty routing, national groups, and large corporate networks. But radiology did not collapse into one national reading room. Hospital-based groups, academic departments, regional networks, outpatient imaging groups, and national teleradiology companies all coexist.
Pathology is likely to follow the same broad pattern: hybrid consolidation, not total centralization.
Why Pathology Is Not Just Radiology With Slides
Radiology is often born digital. The CT or MRI scanner converts the patient directly into a digital imaging study. Pathology is different. The digital image is downstream of a complex physical production process.
Tissue must be collected, accessioned, grossed, fixed, embedded, cut, stained, quality-checked, and sometimes recut or reflexed to special stains, immunohistochemistry, cytogenetics, flow cytometry, or molecular testing. A whole-slide image is therefore not the whole diagnostic enterprise. It is one layer built on top of a specimen workflow.
That difference matters. A remote pathologist can read an image, but pathology also includes specimen stewardship, laboratory quality, intraoperative consultation, clinical communication, tumor board participation, and institutional accountability. These functions are harder to detach from the local hospital or regional health system.
What Will Centralize First
Not all pathology work is equally centralizable. Some areas are especially suited to digital routing.
Subspecialty review. Dermatopathology, gastrointestinal pathology, genitourinary pathology, breast pathology, hematopathology, renal pathology, neuropathology, and complex oncology cases can all benefit from digital access to expert readers.
Second opinions and consultations. Digital pathology can reduce the delay and friction of mailing glass slides, especially for rare tumors, difficult borderline cases, or treatment-defining diagnoses.
Overflow and load balancing. Multi-hospital systems may shift work across their network, smoothing daily volume spikes and making better use of subspecialists.
Quality review and benchmarking. Digital archives make it easier to compare interpretations, audit concordance, monitor turnaround time, and support peer review.
AI-enabled triage. Algorithms may help identify suspicious regions, prioritize urgent cases, standardize quantification, or flag possible discrepancies.
These uses do not require pathology to become fully centralized. They require pathology to become digitally routable.
What Will Stay Local or Regional
Other parts of pathology will remain more locally anchored.
Specimen handling. Tissue still must be processed physically. Fixation, grossing, embedding, sectioning, staining, scanning, and quality control are operationally local or regional.
Frozen sections and urgent intraoperative work. These require tight coordination with operating rooms and clinical teams.
Clinical relationships. Pathologists work with surgeons, oncologists, gastroenterologists, pulmonologists, dermatologists, and tumor boards. Local knowledge still matters.
Laboratory medical direction. Accreditation, quality systems, preanalytic variables, technical problems, and staff supervision require accountable medical leadership.
Multidisciplinary care. In cancer care especially, the pathologist is not merely a remote reader. The pathologist helps connect morphology, immunohistochemistry, molecular results, radiology, staging, and treatment planning.
This is the stabilizing force that makes total centralization unlikely.
The Emerging Market Architecture
Digital pathology may separate the industry into two related but distinct layers.
The slide factory. This includes accessioning, grossing, tissue processing, staining, scanning, image quality control, chain of custody, and LIS/image-system integration.
The interpretation network. This includes primary diagnosis, subspecialty sign-out, second opinions, AI triage, tumor-board support, quality analytics, and diagnostic benchmarking.
These layers can be integrated within one health system, split between local labs and regional hubs, or connected through national specialty networks. The key point is that digital pathology makes the division possible. The slide no longer has to travel physically for the case to travel diagnostically.
The Role of AI and Scale
Artificial intelligence may accelerate consolidation because scale creates data advantages. Large digital archives can support algorithm development, validation, quality review, productivity analytics, and disease-specific workflows. Organizations with large case volumes may gain capabilities that small practices cannot easily reproduce.
But AI could also support decentralization. A community hospital with digital pathology could gain access to triage tools, quantification tools, subspecialty backup, and remote consultation that previously required a major academic center. In that model, digital pathology strengthens local care rather than replacing it.
The strategic question is therefore not whether digital pathology centralizes or decentralizes pathology. It will do both. It will centralize some expertise, standardize some workflows, and distribute some capabilities more widely.
Lessons From Radiology
Radiology offers both a model and a warning. Digital radiology improved access, speed, after-hours coverage, subspecialty consultation, and image availability. It also produced consolidation, productivity pressure, commoditized reads, and tension between remote interpretation and local clinical integration.
Pathology may experience similar pressures, but with a different equilibrium. Radiology images are produced directly by scanners. Pathology images are produced by laboratories. That physical-laboratory foundation gives pathology a stronger local anchor.
The likely future is therefore not a single national pathology factory. It is a layered system: local laboratories, regional hubs, academic and subspecialty networks, national platforms, and AI-enabled quality systems.
Forecast: Hybrid Consolidation, Not Total Centralization
The pathology market is likely to become more digital, more networked, more subspecialized, and more consolidated in selected areas. Some small groups may be squeezed, especially if they lack digital infrastructure, subspecialty depth, or health-system scale. Larger organizations may gain advantages in recruiting, coverage, data, AI, quality systems, and workflow management.
But local pathology will not disappear. Hospitals and health systems will still need pathology leadership tied to specimen quality, lab operations, clinical relationships, tumor boards, frozen sections, and medical staff accountability.
The winners will likely be organizations that combine three capabilities: excellent physical specimen operations, strong digital infrastructure, and flexible interpretation networks. The losers may be organizations that treat digital pathology as simply a scanner purchase rather than a redesign of diagnostic workflow.
Bottom Line
Digital pathology is not merely a new way to look at slides. It is a new market architecture for anatomic pathology. It allows the diagnostic case to move even when the physical tissue remains local.
The profession’s central challenge will be to capture the benefits of digital scale without losing the clinical accountability that has historically defined pathology’s role in patient care. The glass slide will remain important, but it will no longer define the boundaries of the field.
